v3.25.1
SEGMENT INFORMATION
 3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
SEGMENT INFORMATION SEGMENT INFORMATION
Effective July 1, 2024, Image Guided Therapies, previously part of the Imaging segment, was realigned to the Ultrasound segment. The Ultrasound segment was subsequently renamed Advanced Visualization Solutions (“AVS”). Following this realignment, the Company continues to have four reportable segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions (“PCS”), and Pharmaceutical Diagnostics (“PDx”). These segments have been identified based on the nature of the products sold and how the Company manages its operations. We have not aggregated any of our operating segments to form reportable segments. A description of our reportable segments has been provided in Item 1, “Business” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. Historical segment financial information presented within this report has been recast to conform to the new reportable segments structure.
The Company’s organizational structure is based upon the availability of separate financial information that is evaluated regularly by the Company’s Chief Operating Decision Maker (“CODM”) for the purpose of assessing performance and allocating resources. The Company’s CODM is its Chief Executive Officer. The CODM assesses segment performance using Total revenues and an earnings metric defined as “Segment EBIT.” Segment EBIT is calculated as income before income taxes in our Condensed Consolidated Statements of Income excluding the impact of the following: Interest and other financial charges – net, Non-operating benefit (income) costs, restructuring costs, acquisition and disposition-related benefits (charges), gain (loss) on business and asset dispositions, Spin-Off and separation costs, amortization of acquisition-related intangible assets, and investment revaluation gain (loss). Segment EBIT is also used in the annual budget and periodic forecasting processes and informs the CODM in decision making regarding the allocation of resources to the segments.

Total Revenues by Segment
For the three months ended March 31
20252024
Total Imaging$2,140 $2,062 
AVS:
Procedural Guidance641 651 
Specialized Ultrasound598 576 
Total AVS
1,239 1,227 
PCS:
Monitoring Solutions
556 527 
Life Support Solutions
197 220 
Total PCS753 747 
Total PDx632 599 
Other(1)
13 15 
Total revenues$4,777 $4,650 
(1) Financial information not presented within the reportable segments, shown within the Other category, represents HealthCare Financial Services (“HFS”) which does not meet the definition of an operating segment.

Significant Expenses by Segment
For the three months ended March 31
20252024
Imaging:
Cost of sales
$1,353 $1,338 
Other segment items(1)
588 559 
Total Imaging$1,941 $1,897 
AVS:
Cost of sales
$598 $599 
Other segment items(1)
380 371 
Total AVS
$978 $970 
PCS:
Cost of sales
$481 $460 
Other segment items(1)
224 206 
Total PCS$705 $666 
PDx:
Cost of sales
$294 $295 
Other segment items(1)
133 126 
Total PDx$428 $421 
(1) Other segment items for each segment includes selling, general, administrative, research, and development related expenses, as well as other segment income and expenses.
Segment EBIT
For the three months ended March 31
20252024
Segment EBIT
Imaging$199 $166 
AVS
261 257 
PCS 48 81 
PDx 205 178 
Other(1)
2 (1)
715 681 
Restructuring costs(22)(40)
Acquisition and disposition-related benefits (charges)
(8)— 
Gain (loss) on business and asset dispositions
10 — 
Spin-Off and separation costs(24)(60)
Amortization of acquisition-related intangible assets(35)(31)
Investment revaluation gain (loss)92 (20)
Interest and other financial charges – net(110)(122)
Non-operating benefit income (costs)74 102 
Income before income taxes
$692 $512 
(1) Financial information not presented within the reportable segments, shown within the Other category, primarily represents HFS which does not meet the definition of an operating segment.

The following table represents the depreciation and amortization amounts reported within the Segment EBIT metric for our reportable segments. Depreciation and amortization expense related to shared property, plant, and equipment and intangibles, exclusive of acquisition-related intangible assets, has been fully allocated to our segments and those allocations are reflected in the amounts presented in the table below. These amounts are included within Cost of sales and Other segment items disclosed in the Significant Expenses by Segment table above.

Depreciation and Amortization by Segment
For the three months ended March 31
20252024
Imaging$57 $65 
AVS18 21 
PCS 13 15 
PDx 12 16 

The Company does not report total assets by segment as the Company’s CODM does not assess performance, make strategic decisions, or allocate resources based on assets.